Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Harte Hanks (HHS) EBIT (2016 - 2025)

Harte Hanks (HHS) has disclosed EBIT for 16 consecutive years, with $34000.0 as the latest value for Q2 2025.

  • On a quarterly basis, EBIT fell 97.52% to $34000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was -$13.0 million, a 37.31% decrease, with the full-year FY2024 number at $2.1 million, down 37.69% from a year prior.
  • EBIT was $34000.0 for Q2 2025 at Harte Hanks, up from -$16.3 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $4.2 million in Q3 2021 to a low of -$16.3 million in Q4 2024.
  • A 5-year average of -$271250.0 and a median of $1.2 million in 2023 define the central range for EBIT.
  • Peak YoY movement for EBIT: soared 540.5% in 2022, then tumbled 617.6% in 2024.
  • Harte Hanks' EBIT stood at -$1.4 million in 2021, then surged by 351.58% to $3.4 million in 2022, then plummeted by 166.43% to -$2.3 million in 2023, then crashed by 617.6% to -$16.3 million in 2024, then surged by 100.21% to $34000.0 in 2025.
  • Per Business Quant, the three most recent readings for HHS's EBIT are $34000.0 (Q2 2025), -$16.3 million (Q4 2024), and $1.9 million (Q3 2024).